Skip to Main Content

Paper Details

Clinical implications of cancer gene mutations in patients with chronic lymphocytic leukemia treated with lenalidomide.
Blood
34
2018
295 cancer genes, CLL, DDX3X, KRAS, Lenalidomide, MGA mutations, NOTCH1, R/R, SF3B1, SF3B1 mutations, TN, TP53, TP53 mutation, TP53 mutations, cancer, cancer gene, chronic lymphocytic leukemia, del(11q), del(17p), lenalidomide, patients
Author NameAffiliation
Curtis GumbsThe University of Texas MD Anderson Cancer Center
Xingzhi SongApplied Cancer Science Institute, The University of Texas MD Anderson Cancer Center
Xingzhi SongApplied Cancer Science Institute, The University of Texas MD Anderson Cancer Center
Jianhua ZhangThe University of Texas MD Anderson Cancer Center
Jianhua ZhangThe University of Texas MD Anderson Cancer Center
Guillermo Garcia-Manero
Hagop Kantarjian
Phillip A FutrealThe University of Texas MD Anderson Cancer Center
  • 1 - 8

Datasets

Release 1.2